These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 30381536)

  • 41. Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk.
    Hohman TJ; Cooke-Bailey JN; Reitz C; Jun G; Naj A; Beecham GW; Liu Z; Carney RM; Vance JM; Cuccaro ML; Rajbhandary R; Vardarajan BN; Wang LS; Valladares O; Lin CF; Larson EB; Graff-Radford NR; Evans D; De Jager PL; Crane PK; Buxbaum JD; Murrell JR; Raj T; Ertekin-Taner N; Logue MW; Baldwin CT; Green RC; Barnes LL; Cantwell LB; Fallin MD; Go RC; Griffith P; Obisesan TO; Manly JJ; Lunetta KL; Kamboh MI; Lopez OL; Bennett DA; Hardy J; Hendrie HC; Hall KS; Goate AM; Lang R; Byrd GS; Kukull WA; Foroud TM; Farrer LA; Martin ER; Pericak-Vance MA; Schellenberg GD; Mayeux R; Haines JL; Thornton-Wells TA;
    Alzheimers Dement; 2016 Mar; 12(3):233-43. PubMed ID: 26092349
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutation analysis of the MS4A and TREM gene clusters in a case-control Alzheimer's disease data set.
    Ghani M; Sato C; Kakhki EG; Gibbs JR; Traynor B; St George-Hyslop P; Rogaeva E
    Neurobiol Aging; 2016 Jun; 42():217.e7-217.e13. PubMed ID: 27084067
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer's disease.
    De Roeck A; Van den Bossche T; van der Zee J; Verheijen J; De Coster W; Van Dongen J; Dillen L; Baradaran-Heravi Y; Heeman B; Sanchez-Valle R; Lladó A; Nacmias B; Sorbi S; Gelpi E; Grau-Rivera O; Gómez-Tortosa E; Pastor P; Ortega-Cubero S; Pastor MA; Graff C; Thonberg H; Benussi L; Ghidoni R; Binetti G; de Mendonça A; Martins M; Borroni B; Padovani A; Almeida MR; Santana I; Diehl-Schmid J; Alexopoulos P; Clarimon J; Lleó A; Fortea J; Tsolaki M; Koutroumani M; Matěj R; Rohan Z; De Deyn P; Engelborghs S; Cras P; Van Broeckhoven C; Sleegers K;
    Acta Neuropathol; 2017 Sep; 134(3):475-487. PubMed ID: 28447221
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TREM2 and the Progression of Alzheimer's Disease.
    Gao L; Jiang T; Yao X; Yu L; Yang X; Li Y
    Curr Neurovasc Res; 2017; 14(2):177-183. PubMed ID: 28393702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease.
    Jones L; Harold D; Williams J
    Biochim Biophys Acta; 2010 Aug; 1801(8):754-61. PubMed ID: 20420935
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Impact of Complement Genes on the Risk of Late-Onset Alzheimer's Disease.
    Carpanini SM; Harwood JC; Baker E; Torvell M; The Gerad Consortium ; Sims R; Williams J; Morgan BP
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33804666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular mechanisms of the genetic risk factors in pathogenesis of Alzheimer disease.
    Kanatsu K; Tomita T
    Front Biosci (Landmark Ed); 2017 Jan; 22(1):180-192. PubMed ID: 27814610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
    Naj AC; Jun G; Beecham GW; Wang LS; Vardarajan BN; Buros J; Gallins PJ; Buxbaum JD; Jarvik GP; Crane PK; Larson EB; Bird TD; Boeve BF; Graff-Radford NR; De Jager PL; Evans D; Schneider JA; Carrasquillo MM; Ertekin-Taner N; Younkin SG; Cruchaga C; Kauwe JS; Nowotny P; Kramer P; Hardy J; Huentelman MJ; Myers AJ; Barmada MM; Demirci FY; Baldwin CT; Green RC; Rogaeva E; St George-Hyslop P; Arnold SE; Barber R; Beach T; Bigio EH; Bowen JD; Boxer A; Burke JR; Cairns NJ; Carlson CS; Carney RM; Carroll SL; Chui HC; Clark DG; Corneveaux J; Cotman CW; Cummings JL; DeCarli C; DeKosky ST; Diaz-Arrastia R; Dick M; Dickson DW; Ellis WG; Faber KM; Fallon KB; Farlow MR; Ferris S; Frosch MP; Galasko DR; Ganguli M; Gearing M; Geschwind DH; Ghetti B; Gilbert JR; Gilman S; Giordani B; Glass JD; Growdon JH; Hamilton RL; Harrell LE; Head E; Honig LS; Hulette CM; Hyman BT; Jicha GA; Jin LW; Johnson N; Karlawish J; Karydas A; Kaye JA; Kim R; Koo EH; Kowall NW; Lah JJ; Levey AI; Lieberman AP; Lopez OL; Mack WJ; Marson DC; Martiniuk F; Mash DC; Masliah E; McCormick WC; McCurry SM; McDavid AN; McKee AC; Mesulam M; Miller BL; Miller CA; Miller JW; Parisi JE; Perl DP; Peskind E; Petersen RC; Poon WW; Quinn JF; Rajbhandary RA; Raskind M; Reisberg B; Ringman JM; Roberson ED; Rosenberg RN; Sano M; Schneider LS; Seeley W; Shelanski ML; Slifer MA; Smith CD; Sonnen JA; Spina S; Stern RA; Tanzi RE; Trojanowski JQ; Troncoso JC; Van Deerlin VM; Vinters HV; Vonsattel JP; Weintraub S; Welsh-Bohmer KA; Williamson J; Woltjer RL; Cantwell LB; Dombroski BA; Beekly D; Lunetta KL; Martin ER; Kamboh MI; Saykin AJ; Reiman EM; Bennett DA; Morris JC; Montine TJ; Goate AM; Blacker D; Tsuang DW; Hakonarson H; Kukull WA; Foroud TM; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; Schellenberg GD
    Nat Genet; 2011 May; 43(5):436-41. PubMed ID: 21460841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blood clusterin levels, rs9331888 polymorphism, and the risk of Alzheimer's disease.
    Xing YY; Yu JT; Cui WZ; Zhong XL; Wu ZC; Zhang Q; Tan L
    J Alzheimers Dis; 2012; 29(3):515-9. PubMed ID: 22258514
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent studies on cellular and molecular mechanisms in Alzheimer's disease: focus on epigenetic factors and histone deacetylase.
    Dubey H; Gulati K; Ray A
    Rev Neurosci; 2018 Mar; 29(3):241-260. PubMed ID: 29397389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Manifestations of Alzheimer's disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90.
    Heath L; Earls JC; Magis AT; Kornilov SA; Lovejoy JC; Funk CC; Rappaport N; Logsdon BA; Mangravite LM; Kunkle BW; Martin ER; Naj AC; Ertekin-Taner N; Golde TE; Hood L; Price ND;
    Sci Rep; 2022 Apr; 12(1):6117. PubMed ID: 35413975
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetics of Alzheimer's disease: new evidences for an old hypothesis?
    Lambert JC; Amouyel P
    Curr Opin Genet Dev; 2011 Jun; 21(3):295-301. PubMed ID: 21371880
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic determinants of disease progression in Alzheimer's disease.
    Wang X; Lopez OL; Sweet RA; Becker JT; DeKosky ST; Barmada MM; Demirci FY; Kamboh MI
    J Alzheimers Dis; 2015; 43(2):649-55. PubMed ID: 25114068
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
    Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
    Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of CLU and PICALM polymorphisms on AD risk: A study from south India.
    Shankarappa BM; Kota LN; Purushottam M; Nagpal K; Mukherjee O; Viswanath B; Varghese M; Bharath S; Jain S
    Asian J Psychiatr; 2017 Jun; 27():7-11. PubMed ID: 28558900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of CD33 as a genetic risk factor for Alzheimer's disease.
    Estus S; Shaw BC; Devanney N; Katsumata Y; Press EE; Fardo DW
    Acta Neuropathol; 2019 Aug; 138(2):187-199. PubMed ID: 30949760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complement receptor 1 (CR1) and Alzheimer's disease.
    Crehan H; Holton P; Wray S; Pocock J; Guerreiro R; Hardy J
    Immunobiology; 2012 Feb; 217(2):244-50. PubMed ID: 21840620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetics: finding risk factors.
    Eisenstein M
    Nature; 2011 Jul; 475(7355):S20-2. PubMed ID: 21760580
    [No Abstract]   [Full Text] [Related]  

  • 59. Alzheimer's disease genes and cognition in the nondemented general population.
    Verhaaren BF; Vernooij MW; Koudstaal PJ; Uitterlinden AG; van Duijn CM; Hofman A; Breteler MM; Ikram MA
    Biol Psychiatry; 2013 Mar; 73(5):429-34. PubMed ID: 22592056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of the genetic variance of late-onset Alzheimer's disease.
    Ridge PG; Hoyt KB; Boehme K; Mukherjee S; Crane PK; Haines JL; Mayeux R; Farrer LA; Pericak-Vance MA; Schellenberg GD; Kauwe JSK;
    Neurobiol Aging; 2016 May; 41():200.e13-200.e20. PubMed ID: 27036079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.